Literature DB >> 26669117

Chemical Composition of Blumea lacera Essential Oil from Nepal. Biological Activities of the Essential Oil and (Z)-Lachnophyllum Ester.

Prabodh Satyal, Bhuwan K Chhetri, Noura S Dosoky, Samon Shrestha, Ambika Poudel, William N Setzer.   

Abstract

The essential oil from the aerial parts of Blumea lacera collected from Biratnagar, Nepal, has been obtained by hydrodistillation and analyzed by gas chromatography - mass spectrometry. The major component from the oil, (Z)-lachnophyllum ester, was isolated by preparative silica gel chromatography. B. lacera oil was dominated by (Z)-lachnophyllum ester (25.5%), (Z)-lachnophyllic acid (17.0%), germacrene D (11.0%), (E)-β-farnesene (10.1%), bicyclogermacrene (5.2%), (E)-caryophyllene (4.8%), and (E)-nerolidol (4.2%). Also detected in the oil were (E)-lachnophyllic acid (3.3%) and (E)-lachnophyllum ester (1.7%). (Z)-Lachnophyllum ester exhibited cytotoxic activity against MDA-MD-231, MCF-7, and 5637 human tumor cells, as well as antibacterial and antifungal activity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26669117

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  3 in total

Review 1.  Himalayan Aromatic Medicinal Plants: A Review of their Ethnopharmacology, Volatile Phytochemistry, and Biological Activities.

Authors:  Rakesh K Joshi; Prabodh Satyal; Wiliam N Setzer
Journal:  Medicines (Basel)       Date:  2016-02-19

2.  Composition of Essential Oils from Roots and Aerial Parts of Carpesium divaricatum, a Traditional Herbal Medicine and Wild Edible Plant from South-East Asia, Grown in Poland.

Authors:  Anna Wajs-Bonikowska; Janusz Malarz; Anna Stojakowska
Journal:  Molecules       Date:  2019-12-03       Impact factor: 4.411

3.  Chemico-Biological Profiling of Blumea lacera (Burm.f.) DC. (Family: Asteraceae) Provides New Insights as a Potential Source of Antioxidant, Cytotoxic, Antimicrobial, and Antidiarrheal Agents.

Authors:  Sania Ashrafi; Safaet Alam; Ariful Islam; Nazim Uddin Emon; Quazi Sufia Islam; Monira Ahsan
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-12       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.